We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current TPST market cap is 71.99M. The company's latest EPS is USD -1.5322 and P/E is -2.41.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -8.77M | -8.93M | -7.58M | -7.47M | -6.59M |
Net Income | -8.95M | -9.1M | -7.64M | -7.58M | -6.79M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -45.4M | -35.97M | -26.99M | -34.64M | -29.16M |
Net Income | -44.57M | -36.41M | -28.3M | -35.71M | -29.49M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 63.17M | 46.09M | 37.33M | 30.74M | 23.99M |
Total Liabilities | 36.4M | 27.98M | 26.36M | 25.73M | 25.18M |
Total Equity | 26.77M | 18.11M | 10.97M | 5.01M | -1.19M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 74.97M | 43.41M | 73.24M | 46.09M | 51.6M |
Total Liabilities | 15.1M | 9.68M | 37.12M | 27.98M | 24.84M |
Total Equity | 59.87M | 33.73M | 36.12M | 18.11M | 26.77M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -24.59M | -31.07M | -8.3M | -14.7M | -21.18M |
Investing | -206k | -562k | -46k | -163k | -163k |
Financing | 16.13M | 11.4M | 44k | 1.23M | 1.25M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -41.22M | -30.44M | -25.96M | -31.07M | -27.36M |
Investing | 3.99M | -26k | -97k | -562k | -170k |
Financing | 26.94M | 5.39M | 59.06M | 11.4M | 35.6M |
Market Cap | 71.99M |
Price to Earnings Ratio | -2.41 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 1.81 |
Price to Book Ratio | 2.65 |
Dividend Yield | - |
Shares Outstanding | 19.25M |
Average Volume (1 week) | 338.97k |
Average Volume (1 Month) | 562.5k |
52 Week Change | 73.95% |
52 Week High | 9.77 |
52 Week Low | 0.17 |
Spread (Intraday) | 2.75 (42.97%) |
Company Name | Tempest Therpeutics Inc |
Address |
corporation trust center wilmington, delaware 19801 |
Website | https://www.tempesttx.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions